The DOI matches its Crossref record.
Determinants of angiotensin II generation during converting enzyme inhibition.
Open accessAbstract
The reaction of the renin-angiotensin system to acute angiotensin converting enzyme inhibition was investigated in a single-blind, crossover study in nine normal volunteers receiving two out of three regimens in random order: the new converting enzyme inhibitor benazepril (20 mg once or 5 mg four times at 6-hour intervals) or enalapril (20 mg). Plasma converting enzyme activity, drug levels, angiotensin I and angiotensin II, active renin, and aldosterone were measured before and 1-4 hours and 14-30 hours after drug intake. Baseline in vitro plasma converting enzyme activity was 97 +/- 15 nmol/ml/min (mean +/- SD) when Hip-Gly-Gly was used as substrate, but with carbobenzoxy-Phe-His-Leu (Z-Phe-His-Leu) or angiotensin I as substrate it was only 20 +/- 4 and 1.7 +/- 0.3 nmol/ml/min, respectively. Discriminating power at peak converting enzyme inhibition was enhanced with the two latter substrates. In vivo converting enzyme activity was estimated by the plasma angiotensin II/angiotensin I ratio, which correlated well with in vitro converting enzyme activity using Z-Phe-His-Leu as substrate (r = 0.76, n = 252). Angiotensin II levels returned to baseline less than 24 hours after drug administration, whereas in vitro and in vivo converting enzyme activity remained considerably inhibited and active renin together with angiotensin I levels were still elevated. A close linear relation was found between plasma angiotensin II and the angiotensin I/drug level ratio (r = 0.91 for benazeprilat and r = 0.88 for enalaprilat, p less than 0.001). Thus, plasma angiotensin II truly reflects the resetting of the renin-angiotensin system at any degree of converting enzyme inhibition. The ratio of plasma angiotensin II to angiotensin I represents converting enzyme inhibition more accurately than in vitro assays, which vary considerably depending on substrates and assay conditions used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Angiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
Gainer, J. V., Morrow, J. D., Loveland, A., King, D. J., & Brown, N. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810293391804 · Cited by 443
Nussberger, J., Wuerzner, G., Jensen, C., & Brunner, H. R. (2002) · Hypertension · doi:10.1161/hy0102.102293 · Cited by 409
Self-citationMacFadyen, R. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00091-6 · Cited by 339
Azizi, M., Rousseau, A., Ezan, E., Guyene, T. T., Michelet, S., Grognet, J. M., Lenfant, M., Corvol, P., & Ménard, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118484 · Cited by 339
Self-citationSingh, V. P., Le, B., Khode, R., Baker, K. M., & Kumar, R. (2008) · Diabetes · doi:10.2337/db08-0805 · Cited by 332
Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Campbell, D. J., Kladis, A., & Duncan, A. M. (1994) · Hypertension · doi:10.1161/01.hyp.23.4.439 · Cited by 317
Gottlieb, S. S., Dickstein, K., Fleck, E., Kostis, J., Levine, T. B., LeJemtel, T., & DeKock, M. (1993) · Circulation · doi:10.1161/01.cir.88.4.1602 · Cited by 291
Renin inhibition with aliskiren: where are we now, and where are we going?
Azizi, M., Webb, R., Nussberger, J., & Hollenberg, N. K. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000202812.72341.99 · Cited by 253
Self-citationBrosnihan, K. B., Li, P., Ganten, D., & Ferrario, C. M. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.273.6.r1908 · Cited by 156
Feasibility Study of N-of-1 Trials With Blood Pressure Self-Monitoring in Hypertension
Chatellier, G., Day, M., Bobrie, G., & Menard, J. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.294 · Cited by 72
Effects of chronic hormone replacement on the renin–angiotensin system in cynomolgus monkeys
Brosnihan, K. B., Weddle, D., Anthony, M. S., Heise, C., Li, P., & Ferrario, C. M. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715070-00003 · Cited by 70
Schmitt, F., Martinez, F., Brillet, G., Nguyen-Khoa, T., Brouard, R., Sissmann, J., Lacour, B., & Grunfeld, J.-P. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199802000-00019 · Cited by 21
Metadata
- Authors
- Juillerat, L., Nussberger, J., Ménard, J., Mooser, V, Christen, Y., Waeber, B., Graf, P., & Brunner, H. R.
- Venue
- Hypertension
- Published
- 1990-11
- Volume
- 16
- Issue
- 5
- Pages
- 564-572
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2138806344
- Cited by
- 212
- References
- 0
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.